These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
263 related articles for article (PubMed ID: 27043274)
1. Loss of parvalbumin-immunoreactivity in mouse brain regions after repeated intermittent administration of esketamine, but not R-ketamine. Yang C; Han M; Zhang JC; Ren Q; Hashimoto K Psychiatry Res; 2016 May; 239():281-3. PubMed ID: 27043274 [TBL] [Abstract][Full Text] [Related]
2. R-ketamine: a rapid-onset and sustained antidepressant without psychotomimetic side effects. Yang C; Shirayama Y; Zhang JC; Ren Q; Yao W; Ma M; Dong C; Hashimoto K Transl Psychiatry; 2015 Sep; 5(9):e632. PubMed ID: 26327690 [TBL] [Abstract][Full Text] [Related]
3. Reduction of dopamine D Hashimoto K; Kakiuchi T; Ohba H; Nishiyama S; Tsukada H Eur Arch Psychiatry Clin Neurosci; 2017 Mar; 267(2):173-176. PubMed ID: 27091456 [TBL] [Abstract][Full Text] [Related]
4. Loss of phenotype of parvalbumin interneurons in rat prefrontal cortex is involved in antidepressant- and propsychotic-like behaviors following acute and repeated ketamine administration. Zhou Z; Zhang G; Li X; Liu X; Wang N; Qiu L; Liu W; Zuo Z; Yang J Mol Neurobiol; 2015 Apr; 51(2):808-19. PubMed ID: 24973145 [TBL] [Abstract][Full Text] [Related]
5. Antidepressant Efficacy and Tolerability of Ketamine and Esketamine: A Critical Review. Molero P; Ramos-Quiroga JA; Martin-Santos R; Calvo-Sánchez E; Gutiérrez-Rojas L; Meana JJ CNS Drugs; 2018 May; 32(5):411-420. PubMed ID: 29736744 [TBL] [Abstract][Full Text] [Related]
6. Effects of a single bilateral infusion of R-ketamine in the rat brain regions of a learned helplessness model of depression. Shirayama Y; Hashimoto K Eur Arch Psychiatry Clin Neurosci; 2017 Mar; 267(2):177-182. PubMed ID: 27480092 [TBL] [Abstract][Full Text] [Related]
7. Comparison of antidepressant and side effects in mice after intranasal administration of (R,S)-ketamine, (R)-ketamine, and (S)-ketamine. Chang L; Zhang K; Pu Y; Qu Y; Wang SM; Xiong Z; Ren Q; Dong C; Fujita Y; Hashimoto K Pharmacol Biochem Behav; 2019 Jun; 181():53-59. PubMed ID: 31034852 [TBL] [Abstract][Full Text] [Related]
8. Ketamine for Depression, 3: Does Chirality Matter? Andrade C J Clin Psychiatry; 2017 Jun; 78(6):e674-e677. PubMed ID: 28682536 [TBL] [Abstract][Full Text] [Related]
9. Lack of rapid antidepressant effects of Kir4.1 channel inhibitors in a chronic social defeat stress model: Comparison with (R)-ketamine. Xiong Z; Zhang K; Ishima T; Ren Q; Ma M; Pu Y; Chang L; Chen J; Hashimoto K Pharmacol Biochem Behav; 2019 Jan; 176():57-62. PubMed ID: 30502360 [TBL] [Abstract][Full Text] [Related]
10. Rapid-acting antidepressant ketamine, its metabolites and other candidates: A historical overview and future perspective. Hashimoto K Psychiatry Clin Neurosci; 2019 Oct; 73(10):613-627. PubMed ID: 31215725 [TBL] [Abstract][Full Text] [Related]
11. Sex differences in the rapid and the sustained antidepressant-like effects of ketamine in stress-naïve and "depressed" mice exposed to chronic mild stress. Franceschelli A; Sens J; Herchick S; Thelen C; Pitychoutis PM Neuroscience; 2015 Apr; 290():49-60. PubMed ID: 25595985 [TBL] [Abstract][Full Text] [Related]
12. Efficacy of Esketamine Nasal Spray Plus Oral Antidepressant Treatment for Relapse Prevention in Patients With Treatment-Resistant Depression: A Randomized Clinical Trial. Daly EJ; Trivedi MH; Janik A; Li H; Zhang Y; Li X; Lane R; Lim P; Duca AR; Hough D; Thase ME; Zajecka J; Winokur A; Divacka I; Fagiolini A; Cubala WJ; Bitter I; Blier P; Shelton RC; Molero P; Manji H; Drevets WC; Singh JB JAMA Psychiatry; 2019 Sep; 76(9):893-903. PubMed ID: 31166571 [TBL] [Abstract][Full Text] [Related]
13. Comparison of R-ketamine and rapastinel antidepressant effects in the social defeat stress model of depression. Yang B; Zhang JC; Han M; Yao W; Yang C; Ren Q; Ma M; Chen QX; Hashimoto K Psychopharmacology (Berl); 2016 Oct; 233(19-20):3647-57. PubMed ID: 27488193 [TBL] [Abstract][Full Text] [Related]
14. Esketamine nasal spray (Spravato) for treatment-resistant depression. Med Lett Drugs Ther; 2019 Apr; 61(1569):54-57. PubMed ID: 31169797 [No Abstract] [Full Text] [Related]
15. Role of 5-HT1A Receptor Stimulation in the Medial Prefrontal Cortex in the Sustained Antidepressant Effects of Ketamine. Fukumoto K; Iijima M; Funakoshi T; Chaki S Int J Neuropsychopharmacol; 2018 Apr; 21(4):371-381. PubMed ID: 29309585 [TBL] [Abstract][Full Text] [Related]
16. Efficacy and Safety of Fixed-Dose Esketamine Nasal Spray Combined With a New Oral Antidepressant in Treatment-Resistant Depression: Results of a Randomized, Double-Blind, Active-Controlled Study (TRANSFORM-1). Fedgchin M; Trivedi M; Daly EJ; Melkote R; Lane R; Lim P; Vitagliano D; Blier P; Fava M; Liebowitz M; Ravindran A; Gaillard R; Ameele HVD; Preskorn S; Manji H; Hough D; Drevets WC; Singh JB Int J Neuropsychopharmacol; 2019 Oct; 22(10):616-630. PubMed ID: 31290965 [TBL] [Abstract][Full Text] [Related]
17. Urothelial toxicity of esketamine in the treatment of depression. Findeis H; Sauer C; Cleare A; Bauer M; Ritter P Psychopharmacology (Berl); 2020 Nov; 237(11):3295-3302. PubMed ID: 32712681 [TBL] [Abstract][Full Text] [Related]
18. GLYX-13 Produces Rapid Antidepressant Responses with Key Synaptic and Behavioral Effects Distinct from Ketamine. Liu RJ; Duman C; Kato T; Hare B; Lopresto D; Bang E; Burgdorf J; Moskal J; Taylor J; Aghajanian G; Duman RS Neuropsychopharmacology; 2017 May; 42(6):1231-1242. PubMed ID: 27634355 [TBL] [Abstract][Full Text] [Related]
19. Ketamine treatment involves medial prefrontal cortex serotonin to induce a rapid antidepressant-like activity in BALB/cJ mice. Pham TH; Mendez-David I; Defaix C; Guiard BP; Tritschler L; David DJ; Gardier AM Neuropharmacology; 2017 Jan; 112(Pt A):198-209. PubMed ID: 27211253 [TBL] [Abstract][Full Text] [Related]